GlaxoSmithKline has announced that after nine years with the firm, Sir Crispin Davis, Sir Robert Wilson and Larry Culp will stand down from the board.
In addition, the UK firm said that James Murdoch has decided not to stand for re-election.
Sir Christopher Gent, chairman of GSK, said: “James Murdoch has decided to stand down from the board with effect from this year’s AGM.
Friday, January 27, 2012
James Murdoch’s departure rings in changes to GSK’s board | InPharm